• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS T4; RADIOIMMUNOASSAY, TOTAL THYROXINE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS T4; RADIOIMMUNOASSAY, TOTAL THYROXINE Back to Search Results
Catalog Number 09007784190
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/20/2022
Event Type  malfunction  
Manufacturer Narrative
The sample was requested for investigation.
 
Event Description
The initial reporter complained of discrepant high results for 1 patient sample tested for elecsys t3 (t3), elecsys ft3 iii (ft3 iii) and elecsys t4 (t4) on a cobas 8000 core unit compared to the siemens method.This medwatch will cover t4.Refer to medwatch with patient identifier (b)(6) for information on the ft3 iii results and medwatch with patient identifier (b)(6) for information on the t3 results.The t3 result from the roche method was 3.56 ng/ml.The result from the siemens method was 1.13 ng/ml.The ft3 iii result from the roche method was 7.26 pg/ml.The result from the siemens method was 3.22 pg/ml.The t4 result from the roche method was 24.9 ug/dl.The result from the siemens method was 7.78 ug/dl.The roche results were reported outside of the laboratory where they did not correspond to the patient¿s clinical condition.The siemens results were believed to be "normal." the cobas 8000 core unit serial number was (b)(4).
 
Manufacturer Narrative
The sample was received for investigation.The customer's high results for ft3 iii, t4 and t3 were reproduced.Further investigation of the sample confirmed an interference against the streptavidin component of the reagent.This interference caused the high ft3 iii, t4 and t3 results and is covered in product labeling: "in rare cases, interference due to extremely high titers of antibodies to analyte-specific antibodies, streptavidin or ruthenium can occur.These effects are minimized by suitable test design.For diagnostic purposes, the results should always be assessed in conjunction with the patient¿s medical history, clinical examination and other findings." the investigation did not identify a product problem.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS T4
Type of Device
RADIOIMMUNOASSAY, TOTAL THYROXINE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
na
indianapolis, IN 46250
3174767531
MDR Report Key15224980
MDR Text Key305079869
Report Number1823260-2022-02429
Device Sequence Number1
Product Code CDX
UDI-Device Identifier07613336171677
UDI-Public07613336171677
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K961490
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 09/12/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number09007784190
Device Lot Number574371
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/20/2022
Initial Date FDA Received08/15/2022
Supplement Dates Manufacturer Received08/19/2022
Supplement Dates FDA Received09/12/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-